Inkef Capital

Inkef Capital is an Amsterdam-based venture firm originally pension-backed, providing long-term strategic support and capital to Dutch and European life science pioneers as well as technology companies. The healthcare practice focuses on pharma/therapeutics, medical devices, and health IT companies where durable value creation supports the firm’s patient-capital orientation. Their position as one of the largest VCs in the Netherlands gives them deep local network advantages alongside broader European reach.

Inkef participates in Seed, Series A, and Series B rounds, deploying $5M to $25M per investment and taking meaningful ownership positions that warrant active board engagement. Geographic focus is the Netherlands and broader Europe, with selective participation in US-led syndicates where European portfolio companies need transatlantic support.

Founders should expect a thoughtful, long-horizon partner with strong views on company building and capital structure, given the firm’s pension-backed origins. Approach with clear unit economics or a credible path to them, alongside a defensible scientific or technical position. Warm introductions through Dutch life sciences advisors, Inkef portfolio CEOs, or European co-investors will accelerate the process. Expect substantive diligence and patient decision timelines.